ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,073 | -8.6% | 625 | -0.8% | 0.01% | +25.0% |
| Q2 2023 | $42,740 | +25.5% | 630 | +0.3% | 0.01% | +14.3% |
| Q1 2023 | $34,069 | -6.7% | 628 | +3.1% | 0.01% | -12.5% |
| Q4 2022 | $36,516 | +30.4% | 609 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $28,000 | -17.6% | 609 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $34,000 | -20.9% | 609 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $43,000 | +7.5% | 609 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $40,000 | -13.0% | 609 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $46,000 | -4.2% | 609 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $48,000 | -4.0% | 609 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $50,000 | -2.0% | 609 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $51,000 | +27.5% | 609 | 0.0% | 0.01% | +7.7% |
| Q3 2020 | $40,000 | +5.3% | 609 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $38,000 | – | 609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |